BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 11422252)

  • 1. Detection of human cytomegalovirus (HCMV) pp67-mRNA and pp65 antigenemia in relation to development of clinical HCMV disease in renal transplant recipients.
    Degré M; Kristiansen KI; Rollag H; Holter E; Nordal KP
    Clin Microbiol Infect; 2001 May; 7(5):254-60. PubMed ID: 11422252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of late pp67-mRNA by NASBA in peripheral blood for the diagnosis of human cytomegalovirus disease in AIDS patients.
    Blank BS; Meenhorst PL; Pauw W; Mulder JW; van Dijk WC; Smits PH; Roeles F; Middeldorp JM; Lange JM
    J Clin Virol; 2002 Jul; 25(1):29-38. PubMed ID: 12126719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection.
    Mengoli C; Cusinato R; Biasolo MA; Cesaro S; Parolin C; Palù G
    J Med Virol; 2004 Sep; 74(1):78-84. PubMed ID: 15258972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct quantification of human cytomegalovirus immediate-early and late mRNA levels in blood of lung transplant recipients by competitive nucleic acid sequence-based amplification.
    Greijer AE; Verschuuren EA; Harmsen MC; Dekkers CA; Adriaanse HM; The TH; Middeldorp JM
    J Clin Microbiol; 2001 Jan; 39(1):251-9. PubMed ID: 11136779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCMV pp67-mRNA detection by nucleic acid sequence-based amplification in renal transplant patients.
    Merlino C; Bergallo M; Gregori G; Sinesi F; Bollero C; Cavallo R
    New Microbiol; 2002 Jan; 25(1):1-8. PubMed ID: 11837384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.
    Gerna G; Baldanti F; Middeldorp JM; Furione M; Zavattoni M; Lilleri D; Revello MG
    J Clin Microbiol; 1999 Apr; 37(4):902-11. PubMed ID: 10074499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective evaluation of the clinical utility of different methods for the detection of human cytomegalovirus disease after liver transplantation.
    Seehofer D; Meisel H; Rayes N; Stein A; Langrehr JM; Settmacher U; Neuhaus P
    Am J Transplant; 2004 Aug; 4(8):1331-7. PubMed ID: 15268736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].
    Özkarata E; Özbek ÖA; Avkan Oğuz V; Sayıner AA
    Mikrobiyol Bul; 2016 Jan; 50(1):44-52. PubMed ID: 27058328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification.
    Blok MJ; Goossens VJ; Vanherle SJ; Top B; Tacken N; Middeldorp JM; Christiaans MH; van Hooff JP; Bruggeman CA
    J Clin Microbiol; 1998 May; 36(5):1341-6. PubMed ID: 9574702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients.
    Gerna G; Baldanti F; Lilleri D; Parea M; Alessandrino E; Pagani A; Locatelli F; Middeldorp J; Revello MG
    J Clin Microbiol; 2000 May; 38(5):1845-53. PubMed ID: 10790111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "pp65 antigenemia and real time polymerase chain reaction (PCR) based-study to determine the prevalence of human cytomegalovirus (HCMV) in kidney donors and recipients with follow-up studies".
    Madhavan HN; Samson MY; Ishwarya M; Vijayakumar R; Jambulingam M
    Virol J; 2010 Nov; 7():322. PubMed ID: 21080922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays.
    Amorim ML; Cabeda JM; Seca R; Mendes AC; Castro AP; Amorim JM
    BMC Infect Dis; 2001; 1():2. PubMed ID: 11389774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of human cytomegalovirus, HHV-6 and HHV-7 infection in kidney transplant recipients by molecular methods to predict HCMV disease after transplantation: a prospective study.
    Rayes N; Seehofer D; Lullius SG; Stein A; May G; Kahl A; Frei U; Neuhaus P; Meisel H
    Ann Transplant; 2005; 10(2):23-8. PubMed ID: 16218029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between pp65 antigenemia levels and real-time quantitative DNA PCR for Human Cytomegalovirus (HCMV) management in immunocompromised patients.
    Cariani E; Pollara CP; Valloncini B; Perandin F; Bonfanti C; Manca N
    BMC Infect Dis; 2007 Nov; 7():138. PubMed ID: 18036216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial.
    Gerna G; Baldanti F; Lilleri D; Parea M; Torsellini M; Castiglioni B; Vitulo P; Pellegrini C; Viganò M; Grossi P; Revello MG
    Transplantation; 2003 Apr; 75(7):1012-9. PubMed ID: 12698090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic implications of human cytomegalovirus immediate early-1 and pp67 mRNA detection in whole-blood samples from liver transplant patients using nucleic acid sequence-based amplification.
    Blok MJ; Lautenschlager I; Goossens VJ; Middeldorp JM; Vink C; Höckerstedt K; Bruggeman CA
    J Clin Microbiol; 2000 Dec; 38(12):4485-91. PubMed ID: 11101584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic value of nucleic-acid-sequence- based amplification for the detection of cytomegalovirus infection in renal and liver transplant recipients.
    Goossens VJ; Blok MJ; Christiaans MH; van Hooff JP; Sillekens P; Höckerstedt K; Lautenschlager I; Middeldorp JM; Bruggeman CA
    Intervirology; 1999; 42(5-6):373-81. PubMed ID: 10702720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients.
    Blank BS; Meenhorst PL; Mulder JW; Weverling GJ; Putter H; Pauw W; van Dijk WC; Smits P; Lie-A-Ling S; Reiss P; Lange JM
    J Clin Microbiol; 2000 Feb; 38(2):563-9. PubMed ID: 10655346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical value of human cytomegalovirus phosphoprotein 65 in the diagnosis of cytomegalovirus disease].
    Yang J; Wang D
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):263-5. PubMed ID: 18250058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients.
    Greijer AE; Verschuuren EA; Dekkers CA; Adriaanse HM; van der Bij W; The TH; Middeldorp JM
    J Infect Dis; 2001 Aug; 184(3):247-55. PubMed ID: 11443549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.